Results 81 to 90 of about 26,897 (178)

Barriers in the control of schistosomiasis with mass distribution of praziquantel in Bauchi State, Nigeria: a phenomenological study

open access: yesDiscover Health Systems
Background Schistosomiasis is a major public health problem in sub-Saharan Africa. Despite the World Health Organization’s recommendation for a widespread distribution of praziquantel, the prevalence of schistosomiasis continues to be alarmingly high ...
Sunday Charles Adeyemo   +9 more
doaj   +1 more source

Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs [PDF]

open access: yes, 2009
Treatment with praziquantel (PZQ) has become virtually the sole basis of schistosomiasis control in sub-Saharan Africa and elsewhere, and the drug is reviewed here in the context of the increasing rate that it is being used for this purpose. Attention is
A. MBAYE   +22 more
core   +2 more sources

The Edna McConnell Clark Foundation's Tropical Disease Research Program: A 25-Year Retrospective Review 1976-1999 [PDF]

open access: yes, 2000
Documents and details the foundation's commitment to the program from its inception, and provides an analysis of its successes until the completion of the program in ...
Barnett L. Cline   +2 more
core  

Praziquantel (Droncit) is effective against diplostomosis of grasscarp Ctenopharyngodon idella and silver carp Hypophthalmichthys molitrix [PDF]

open access: yes, 1991
In laboratory experiments praziquantel (Droncit) effectively destroyed metacercariae of Diplostomum spathaceum (s. l.) parasitizing the eye lens of grasscarp Ctenopharyngodon idella and silver carp Hypophthalmichthys molitrix.
Molnár, Kálmán, Székely, Csaba
core   +1 more source

Praziquantel [PDF]

open access: yesReactions Weekly, 2020
Ronak G. Gandhi, Ramy H. Elshaboury
  +4 more sources

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules

open access: yesPharmaceuticals, 2018
Schistosomiasis is a major neglected tropical disease. Control of schistosomiasis currently relies on a single drug, praziquantel, and despite its efficacy against the all schistosome species that parasitize humans, it displays some problematic drawbacks
Maria João Gouveia   +4 more
doaj   +1 more source

A Large Mass on the Thigh

open access: yes
JEADV Clinical Practice, Volume 5, Issue 1, Page 337-339, March 2026.
Claudine Howard‐James   +5 more
wiley   +1 more source

Rare trematode infestation in irritable bowel syndrome: Pathogen or commensal?

open access: yesJournal of Digestive Endoscopy, 2016
A healthy young adult male presented with complaints of frequent (>3/day) formed stools and passage of excessive mucous in stool for 3 months. He did not complain of nocturnal motions, recent diarrhea, blood in stool, straining, weight loss, or pain ...
Sunit K. Shukla   +3 more
doaj   +1 more source

Resolution of Praziquantel

open access: yesPLoS Neglected Tropical Diseases, 2011
Praziquantel remains the drug of choice for the worldwide treatment and control of schistosomiasis. The drug is synthesized and administered as a racemate. Use of the pure active enantiomer would be desirable since the inactive enantiomer is associated with side effects and is responsible for the extremely bitter taste of the pill.We have identified ...
Michael Woelfle   +5 more
openaire   +4 more sources

A qualitative assessment of community perceptions and practices towards schistosomiasis prior to introduction of a potential novel treatment option for preschool-age children in Kenya

open access: yesFrontiers in Tropical Diseases
BackgroundOver 50 million preschool-age children (PSAC) in Africa need treatment for schistosomiasis but are excluded due to lack of a suitable child-friendly medication. The Paediatric Praziquantel Consortium has developed a novel paediatric formulation
Janet Masaku   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy